A human feasibility trial was conducted to assess the alarm sensitivity and specificity of a novel continuous glucose monitor designed for the ICU setting.
Feasibility data for ICU glucose monitor alarms warrant further development; larger validation trials needed before clinical use.
The ability of a continuous glucose monitor (CGM) to provide actionable information is of utmost importance in the critical care setting. Medtronic has developed a new CGM specifically for the hospital environment. A human feasibility trial was conducted to assess the performance of this system in the ICU. While often overlooked, alarm performance is essential to characterizing both the safety and value of any clinical system - especially in a critical care setting. An analysis was conducted on the sensitivity and specificity of the alarm algorithm to simulate the expected performance when used in the clinical setting.
No takes yet. Share an insight, caveat, or question.
Gottlieb et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: